Solveig Hofvind is head of the Section of breast cancer screening at the Cancer Registry of Norway, and since 2013 has been the head of BreastScreen Norway, a nationwide screening program where women aged 50 to 69 are invited to mammography screening every other year. Hofvind also works with research on breast cancer and screening, with a main focus on epidemiology, artificial intelligence, risk and prognosis, diagnostics and treatment. She is involved in a number of national and international research collaborations. Hofvind has 15 years' experience as radiographer within breast cancer and mammography. She obtained her master’s degree from the Norwegian School of Sports Sciences, where she researched physical activity and risk of breast cancer. In 2005, she was awarded a Dr. Philos from the University of Oslo. She was approved as a Professor in 2010. Hofvind also holds a position as Professor of Radiography at UiT, The Arctic University of Norway.
Solveig Hofvind is head of the Section for breast cancer screening at the Cancer Registry of Norway, and since 2013 has been head of BreastScreen Norway, a nationwide screening program that invites women aged 50 to 69 to mammography screening every two year.
As head of BreastScreen Norway, Hofvind is responsible for the administration, quality assurance and development of the screening program. She has a strong focus on the practical operation of the program, both locally and in the individual health trusts. In addition, she has an extensive research intrest within breast cancer and screening research, with a main focus on epidemiology, artificial intelligence, risk and prognosis, diagnostics and treatment.
She is an active supervisor and has supervised several doctoral and postdoctoral fellows.
Hofvind is a widely used speaker and lecturer, both in nationally and internationally, on topics related to breast cancer screening, and is actively involved in a number of national and international research collaborations.
Hofvind holds a position as Professor of Radiography at UiT, The Arctic University of Norway. She previously held a position as Professor of Radiography at OsloMet, 2007-21, and was a Visiting Professor at the University of Vermont in 2006-07 and 2010-11.
Solveig Hofvind has a background as a radiographer, and has worked for 15 years as a radiographer, mainly with breast cancer and mammography. She obtained her master’s degree from the Norwegian School of Sports Sciences, where she researched physical activity and risk of breast cancer.
In 2005, she defended the degree Dr. Philos at the University of Oslo with the thesis "The Norwegian Breast Cancer Screening Program: Selected Process Indicators and their Utilization in Epidemiological Research". She was approved as professor in 2010.
Hofvind leads, supervises and participates in numerous research projects, including:
- AIMS Norway
- Developement of AI algorithms in BreastScreen Norway
- Advantages and disadvantages of artificial intelligence in BreastScreen Norway
- BADDI: Artificial intelligence in screening with standard mammography and tomosynthesis
- How quickly do breast cancers grow?
- The To-Be studies
- Effectiveness of tomosynthesis in breast cancer screening
- ImmigrantScreen
- Long-term effects following treatment of screen-detected versus symptomatic breast cancer
Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program
Radiology, 303 (3), 502-511
DOI 10.1148/radiol.212381, PubMed 35348377
Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA, Cairns JA, Hofvind S (2021)
Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
Qual Life Res
DOI 10.1007/s11136-021-03017-7, PubMed 34698976
Hofvind S, Moshina N, Holen ÅS, Danielsen AS, Lee CI, Houssami N, Aase HS, Akslen LA, Haldorsen IS (2021)
Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening
Radiology, 300 (1), 66-76
DOI 10.1148/radiol.2021203936, PubMed 33973840
Sebuødegård S, Botteri E, Hofvind S (2020)
Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway
J Natl Cancer Inst, 112 (8), 839-846
DOI 10.1093/jnci/djz220, PubMed 31848605
Hoff SR, Myklebust TÅ, Lee CI, Hofvind S (2019)
Influence of Mammography Volume on Radiologists' Performance: Results from BreastScreen Norway
Radiology, 292 (2), 289-296
DOI 10.1148/radiol.2019182684, PubMed 31135295
Hofvind S, Holen ÅS, Aase HS, Houssami N, Sebuødegård S, Moger TA, Haldorsen IS, Akslen LA (2019)
Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial
Lancet Oncol, 20 (6), 795-805
DOI 10.1016/S1470-2045(19)30161-5, PubMed 31078459
Bhargava S, Akslen LA, Bukholm IRK, Hofvind S (2019)
Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme
Eur Radiol, 29 (9), 4833-4842
DOI 10.1007/s00330-019-6009-2, PubMed 30762109
See all publications in PubMed
